Companies

Malin’s underlying share price jumps 20% after investment in US cancer firm surges

The life sciences investment company, which is backed by Isif, has seen its underlying share price jump to €7.91 in the opening months of 2024

Eoin O'Hare
February 28, 2024

Malin Corporation holds minority stakes in a number of life science and biotech companies. Picture: Paul Nunberg

LATEST NEWS

05:30Sinn Féin’s populist and opportunistic immigration plan is a desperate attempt to shore up its vote
05:15Aileesh Carew’s diary: From welcoming the Indian ambassador, to trying to top the NYPD choir
05:00Book Review: A thriller less ordinary, All The Colours of the Dark makes for a memorable read
05:00Tastemaker: Artist Majella O’Neill Collins - ‘I like a little bit of quietness as I get older’
05:00Two fuss-free and flavourful dishes from bestselling author Rukmini Iyer
05:00‘Greatest pay award’ in 30 years: How the Aer Lingus deal was done and what it means for both sides

LATEST NEWS